Table 2.

A summary of assessments and data collection

Events	Screening visit	Baseline visit	Randomisation	Treatment period		Early termination assessment
				Interim assessment (after 20th treatment session)	End-of-treatment assessment (after 40th treatment session/14 weeks post first treatment visit)	End-of-study follow-up assessment (24 weeks post first treatment visit)
Consent
Informed consent form	×
Eligibility
Inclusion/exclusion criteria	×
Enrolment			×
Interventions
MyndMove therapy
Intensive conventional therapy
Assessments
Demographics and social status		×
General health history		×
History of injury event		×
Neurological	×	×
Blood pressure	×	×*		×*	×*	×*
Functional assessments
SCIM	×	×		×	×	×
GRASSP		×		×	×	×
TRI-HFT		×			×	×
Participation and quality of life
AE/SAE				×	×	×
SCI-QOL		×			×	×
Healthcare resource utilisation questionnaire		×		×	×	×
End of Therapy Questionnaire					×

×*=blood pressure is only required if the measurement is deemed abnormal or up to investigator’s discretion.

AE, adverse event; GRASSP, Graded Redefined Assessment of Strength, Sensibility and Prehension; SAE, serious adverse event; SCIM, Spinal Cord Independence Measure III; SCI-QOL, Spinal Cord Injury-Quality of Life; TRI-HFT, Toronto Rehab Institute Hand Function Test.